Provided by Tiger Trade Technology Pte. Ltd.

Zai Lab Ltd

17.72
-0.7000-3.80%
Post-market: 17.990.2700+1.52%17:49 EST
Volume:961.27K
Turnover:16.89M
Market Cap:1.97B
PE:-11.06
High:17.82
Open:17.38
Low:17.10
Close:18.42
52wk High:44.34
52wk Low:15.96
Shares:111.00M
Float Shares:109.37M
Volume Ratio:1.49
T/O Rate:0.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6026
EPS(LYR):-1.6026
ROE:-22.56%
ROA:-12.16%
PB:2.75
PE(LYR):-11.06

Loading ...

Zai Lab Ltd (1ZLB) Gets a Buy from Guotai Haitong

TIPRANKS
·
Jan 30

Haitong International Maintains "Outperform" Rating on Zai Lab (09688), Sees Dual Engines Driving Long-Term Global Value

Stock News
·
Jan 30

Citi Keeps Their Buy Rating on Zai Lab (ZLAB)

TIPRANKS
·
Jan 15

Zhutong Hong Kong Stock Morning Briefing | Ministry of Finance Holds Meeting on Fiscal-Financial Synergy to Boost Domestic Demand; White House Announces 25% Tariff Hike on Specific Semiconductors

Stock News
·
Jan 15

Zai Lab Rises Over 7% in Morning Session Following Appearance at JPMorgan Healthcare Conference

Deep News
·
Jan 14

Asian Equities Traded in the US as American Depositary Receipts Slightly Higher in Tuesday Trading

MT Newswires Live
·
Jan 13

Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Monday Trading

MT Newswires Live
·
Jan 12

Zai Lab Initiated at Buy by UBS

Dow Jones
·
Jan 08

UBS Initiates Zai Lab at Buy With $35 Price Target

MT Newswires Live
·
Jan 07

Assessing Zai Lab (ZLAB) Valuation After Recent Share Price Volatility

Simply Wall St.
·
Jan 06

Asian Equities Traded in the US as American Depositary Receipts Climb in Friday Trading

MT Newswires Live
·
Jan 02

HK Stock Movement | Zai Lab (09688) Rises Over 4% in Early Trading as Breakthrough Schizophrenia Drug KAI JIE LE Gains Approval in China

Stock News
·
Dec 24, 2025

Zai Lab Says New Drug Application for Schizophrenia Treatment Cobenfy Approved by China's National Medical Products Administration

MT Newswires Live
·
Dec 23, 2025

How Investors May Respond To Zai Lab (ZLAB) Advancing ZL-1503 Into Global Phase 1/1b Atopic Dermatitis Trial

Simply Wall St.
·
Dec 19, 2025

Asian Equities Traded in the US as American Depositary Receipts Lower in Friday Trading; Ends Week Flat

MT Newswires Live
·
Dec 12, 2025

How Investors Are Reacting To Zai Lab (ZLAB) Advancing ZL-1503 And Securing Key NRDL Renewals

Simply Wall St.
·
Dec 10, 2025

Zai Lab Begins Phase 1/1b Study of Atopic Dermatitis Therapy

MT Newswires Live
·
Dec 08, 2025

Zai Lab Says China Renews 3 Medicines in 2025 National Reimbursement Drug List

MT Newswires Live
·
Dec 08, 2025

Zai Lab (09688) Grants Stock Options and Restricted Share Units

Stock News
·
Dec 03, 2025

A Look at Zai Lab (NasdaqGM:ZLAB) Valuation Following Q3 2025 Results and Pipeline Progress

Simply Wall St.
·
Dec 02, 2025